Cite
HARVARD Citation
Kim, K. et al. (2015). Anti-diabetic efficacy of KICG1338, a novel glycogen synthase kinase-3β inhibitor, and its molecular characterization in animal models of type 2 diabetes and insulin resistance. Molecular and cellular endocrinology. pp. 1-10. [Online].